Recombinetics Obtains $250,000 Series A Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2575 University Avenue West Saint Paul, MN 55114
  • Company Description
    At Recombinetics, we use unique precision genetics technologies to provide scientists who study persistent health risks — obesity, diabetes, cancer, and high heart disease –with the research tools they need to understand and combat disease.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Recombinetics hopes to ramp up production to 600 diseased pigs per year by 2016.
  • M&A Terms
  • Venture Investor

Trending on Xconomy